Financials

News Ideas Discussions Technicals Seasonals

BGLC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of BioNexus Gene Lab Corp

Total assets of BGLC for Q2 24 is 11.14 M USD, 0.19% less than the previous Q1 24. And total liabilities decreased by 12.29% in Q2 24 to 1.59 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—